Alex N. Tinega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alex N. Tinega has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Andrew P. Fontenot
Department of Medicine
1 shared publication - Angela M. Mitchell
Research, Lupus Research Alliance, New York, New York, USA
1 shared publication - Avinash Ravindran
Department of Medicine, Solna, Karolinska University Hospital, Stockholm, Sweden 2
1 shared publication - Clemencia Pinilla
Department of Medicinal Chemistry, Institute for Translational Neuroscience, University of Minnesota, Minneapolis, MN 55455, USA
1 shared publication - Douglas G. Mack
Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 1
1 shared publication - Johan Grunewald
Respiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 19 August 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (10)
CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope
Löfgren’s syndrome (LS) is an acute form of sarcoidosis characterized by a genetic association with HLA-DRB1*03 (HLA-DR3) and an accumulation of CD4+ T cells of unknown specificity in the bronchoalveolar lavage (BAL). Here, we screened related LS-specific TCRs for antigen specificity and identified a peptide derived from NAD-dependent histone deacetylase hst4 (NDPD) of Aspergillus nidulans that stimulated these CD4+ T cells in an HLA-DR3–restricted manner. Using ELISPOT analysis, a greater number of IFN-γ– and IL-2–secreting T cells in the BAL of DR3+ LS subjects compared with DR3+ control subjects was observed in response to the NDPD peptide. Finally, increased IgG antibody responses to A. nidulans NDPD were detected in the serum of DR3+ LS subjects. Thus, our findings identify a ligand for CD4+ T cells derived from the lungs of LS patients and suggest a role of A. nidulans in the etiology of LS.
- 19 August 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (10)
Open AccessCD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope
Löfgren’s syndrome (LS) is an acute form of sarcoidosis characterized by a genetic association with HLA-DRB1*03 (HLA-DR3) and an accumulation of CD4+ T cells of unknown specificity in the bronchoalveolar lavage (BAL). Here, we screened related LS-specific TCRs for antigen specificity and identified a peptide derived from NAD-dependent histone deacetylase hst4 (NDPD) of Aspergillus nidulans that stimulated these CD4+ T cells in an HLA-DR3–restricted manner. Using ELISPOT analysis, a greater number of IFN-γ– and IL-2–secreting T cells in the BAL of DR3+ LS subjects compared with DR3+ control subjects was observed in response to the NDPD peptide. Finally, increased IgG antibody responses to A. nidulans NDPD were detected in the serum of DR3+ LS subjects. Thus, our findings identify a ligand for CD4+ T cells derived from the lungs of LS patients and suggest a role of A. nidulans in the etiology of LS.